The Pipeline Ownership Audit
Who owns the number?
Isovertic is the growth agency for healthcare, pharma, biotech, medical devices, and life sciences. A commercial system should produce one simple answer for the person signing the checks: who agreed what counts as a qualified meeting, who checked that the meeting was held, and what it cost. We do not promise how many. If the website team owns visits, the ad vendor owns clicks, and sales owns the missed follow-up, you do not have one answer. You have four reports and a familiar problem.
The Pipeline Ownership Audit is a six-minute self-assessment for CEOs, presidents, chief operating officers, chief financial officers, VPs of commercial, VPs of marketing, chief medical officers, medical directors, practice administrators, and directors of billing. Answer ten questions. You receive a score, a package recommendation, and a written diagnosis you can keep or ignore. Nobody calls you unless you ask.
Ten questions about the work you already pay for
The audit asks how many vendors you have, who owns the number, how many meetings you booked last month, what each one cost, and when you need the next ones. Those questions show whether anyone is accountable for the commercial result.
It also asks about publishing cadence, your written definition of a qualified meeting, regulated buyers (HIPAA, FDA 510(k) and PMA pathways, MLR review), sales-cycle length, and the reason you are looking now. Those details help decide what should be repaired first and what kind of engagement makes sense.
The score is not a grade. A higher score means the ownership gap is wider and the repair may be worth more. A lower score can mean you should start smaller and measure, or that the work is already in good hands.
The question behind the score
Your chief executive officer should be able to ask a direct question: how many qualified meetings did we receive last month, what did they cost, and what happened after our team followed up?
If the answer requires four calendars, three vendors, and a week of archaeology, the commercial work is not connected. The issue may be the site, the follow-up, the advertising, or simply unclear responsibility. The audit is built to separate those possibilities.
You will not get a vague recommendation to improve visibility. You will get a practical diagnosis of the gap and the next reasonable step.
What a useful result can say
Sometimes the issue is the website. A buyer arrives but cannot find proof, pricing, or a clear next step in language a chief scientific officer, principal investigator, or director of billing recognizes. The first repair is Build, included in every package at $15,000 across the year.
Sometimes the site is ready but nobody is publishing enough useful answers for the people already looking. The right start is Ground State at $3,000 per month: one published article, one newsletter to your list, eight social posts, and a monthly report.
Sometimes your company needs meetings sooner and has at least $1,000 a month for Google Ads. Excitation at $5,000 per month plus spend adds a managed campaign, a landing page, and automated follow-up within 30 seconds.
Sometimes the calendar needs direct help. Amplification at $10,000 per month plus spend adds a dedicated person calling and emailing your prospects. We agree what counts as a qualified meeting, we check that the meeting was held, and we report the cost. We do not promise how many. If you have capable internal people but no shared operating process, Protocol training may be the better answer at $5,000 for one department or $20,000 for the full team.
Sometimes the answer is Quantum Leap from $25,000 per month plus spend, the full program for later-stage healthcare, pharma, biotech, medical device, and life sciences tools and diagnostics companies, on one brand or several.
The audit can also say you do not need us. That result saves you time and preserves our calendar for teams we can help. Everyone survives.
Regulated buyers get different recommendations
If your buyers are on the healthcare side, the audit factors in HIPAA. Our compliance layer is $750 per month for a form-and-call stack built against HHS OCR guidance on online tracking technologies and the June 2024 ruling in AHA v. Becerra. The 2023 FTC action against GoodRx is a useful reminder of what happens when a healthcare site leaks protected data through third-party pixels.
If your buyers include a chief medical officer, a medical director, a VP of regulatory, or a principal investigator reviewing claims, the audit checks for MLR review capacity. Our review gate is $500 to $1,200 per month plus setup: a named reviewer, a sign-off log for every asset, and a claim library your team can reuse.
The audit does not make promises it cannot keep
A small advertising budget may produce a qualified meeting a week rather than a flood. That can still be a good outcome if the meeting fits your sale. Sydra Health went from no online presence in mid-June 2026 to about one qualified meeting a week on roughly $1,000 in monthly ad spend and the entry package of site work. Internal, September 2026.
The system moves fastest when your buyers already search in specific language: a gene name, a device model, a regulation, a billing code, a protocol, a clinical question. When nobody is searching yet, the honest answer is not that you have no market. It is that we have to go find the audience with calls and emails, LinkedIn, and the trade press first, which costs more per meeting and takes longer to show. We will not describe it as a fit merely because a website needs updating.
A 12-month engagement is standard because search visibility can take four months to a year, per Google Search Central. We report the work every 30 days and review pipeline and revenue at months six and 12 against your actual sales cycle.
Take the Isovertic move.
If you know which package you want, start on the pricing page with card or bank debit. No call required.
If your commercial work is spread across vendors who cannot explain the meeting number, book a pipeline call and send us your best-converting landing page. In about ten minutes we will tell you what is broken, whether the fix is the site or the follow-up, and what a rebuild would cost, or whether you need one at all. Sometimes the honest answer is you are already fine, and we are happy to say so and hand you back your afternoon.
The people behind the system.
George Stoff, Founder and Lead Engineer
Full-stack engineer with more than 30 years building the systems companies sell through. He built the method Isovertic runs on and stays on every account as the standards owner and the escalation path. When search algorithms shift or a compliance question comes up, you get his engineering judgment. Day-to-day execution runs on the team he trained.
Kristen Coughlin, Chief Operating Officer
Trained molecular biologist. Ten years selling translational research products, then institutional operations at the Yale School of Medicine. She documented George's method, trained the team on it, and built the operation so the same system runs the same way on every account.